Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Most women with excessive hair growth have a hormonal cause.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.